Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymalfasin to Prevent COVID-19 in Renal Dialysis Patients
NCT04428008Phase 2Completed
- Start
- Jan 2021
- Primary completion
- Jan 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin alpha 1 in coronavirus disease 2019 (COVID-19). Started Jan 2021; status: completed.
02
Drugs
thymosin alpha 1
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04428008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04428008.